Close Menu

NEW YORK – Mobidiag said on Tuesday that it has signed exclusive distribution agreements for its Amplidiag and Novodiag molecular diagnostic products in Europe and the Middle East.

Specifically, the Espoo, Finland-based firm signed distribution agreements for its products with Alab in Poland and the Ukraine; Biogenetix in Romania; and Theranostica in Israel.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.